CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Agitated saline pushother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04051541
NCT04051541N/ACompleted

Simulation of Adenosine Push Methods for Treatment of SVT Using Agitated Saline Visualized by Ultrasound

HealthPartners Institute·interventional·Posted Aug 9, 2019·Updated Jul 3, 2023

In Brief

A clinical study evaluating Agitated saline push for Supraventricular Tachycardia. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Supraventricular tachycardia (SVT) is an abnormally fast heart rhythm arising from improper electrical activity in the upper part of the heart. SVT is commonly treated with adenosine using three different IV administration techniques. However, it is not well known which of these three techniques is the quickest or most likely to reach the heart in order to stop SVT. This study will simulate each of those techniques in an investigator-blinded procedure. Intravenous agitated saline, used as a surrogate for a dose of adenosine, will be administered to healthy volunteers using all three techniques and monitored using bedside ultrasound to observe their efficacy and speed in reaching the right side of the heart.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedAug 9, 2019
Enrollment StartMay 6, 2019
Primary CompletionJun 28, 2019
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 6.9 years ago

Interventions

Agitated saline pushother

Push of agitated saline to simulate adenosine used for supraventricular tachycardia